GLP-2 has also been shown to enhance intestinal epithelial barrier function, affecting both paracellular and transcellular permeation pathways, which may reduce local inflammation and improve NAFLD (Benjamin et al., 2000; Cani et al., 2009). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.